chr19-50252727-G-A
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001145809.2(MYH14):c.1919G>A(p.Arg640Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000515 in 1,595,566 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R640W) has been classified as Likely benign.
Frequency
Consequence
NM_001145809.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MYH14 | NM_001145809.2 | c.1919G>A | p.Arg640Gln | missense_variant | 16/43 | ENST00000642316.2 | NP_001139281.1 | |
MYH14 | NM_001077186.2 | c.1919G>A | p.Arg640Gln | missense_variant | 16/42 | NP_001070654.1 | ||
MYH14 | NM_024729.4 | c.1895G>A | p.Arg632Gln | missense_variant | 15/41 | NP_079005.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MYH14 | ENST00000642316.2 | c.1919G>A | p.Arg640Gln | missense_variant | 16/43 | NM_001145809.2 | ENSP00000493594.1 |
Frequencies
GnomAD3 genomes AF: 0.000506 AC: 77AN: 152128Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000677 AC: 148AN: 218616Hom.: 0 AF XY: 0.000763 AC XY: 90AN XY: 118008
GnomAD4 exome AF: 0.000515 AC: 744AN: 1443320Hom.: 0 Cov.: 30 AF XY: 0.000545 AC XY: 390AN XY: 716220
GnomAD4 genome AF: 0.000506 AC: 77AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.000510 AC XY: 38AN XY: 74442
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 15, 2024 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | MYH14: BP4, BS1 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 14, 2020 | This variant is associated with the following publications: (PMID: 23804846) - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 30, 2014 | Variant classified as Uncertain Significance - Favor Benign. The p.Arg640Gln var iant in MYH14 has not been previously reported in individuals with hearing loss. This variant has been identified in 0.2% (52/26604) of European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs 199696801). Although this variant has been seen in the general population, its f requency is not high enough to rule out a pathogenic role. Computational predict ion tools and conservation analyses suggest that the Arg640Gln variant may not i mpact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, while the clinical significance of the p.Arg640Gln va riant is uncertain, these data suggest that it is more likely to be benign. - |
Autosomal dominant nonsyndromic hearing loss 4A Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Apr 27, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. - |
MYH14-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 10, 2021 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at